Lasa Supergenerics Fair Value

Lasa Supergenerics (LASA) average fair value is ₹36.33 across 4 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF), vs a current market price of ₹7.88 (+361.04%), fair value range ₹0.42–₹73.25. For live price and a broader fundamental view, visit LASA stock overview.

Average Fair Value
₹36.33
Current Market Price: ₹7.88
+361.04% Price Difference

Fair Value Analysis Export

LASA Fair Value vs Current Price — Valuation Summary

LASA average fair value, fair value range, price gap and valuation status across 4 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF). Explore LASA fundamental worth to estimate fundamental worth using multiple valuation models.

Average Fair Value
₹36.33
Current Market Price
₹7.88
Price Difference
₹28.45
Percentage Difference
+361.04%
Fair Value Range
₹0.42 - ₹73.25
Methods Used
4
Analysis based on 4 valuation methods: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF)

P/B Based Valuation

Book Value/Share ₹16.8
Sector Avg P/B 5.03
Historical Avg P/B N/A
Average Fair Value
₹54.85

Price-to-Sales Valuation

Revenue/Share ₹18.31
Sector Avg P/S 4.0
Fair Value
₹73.25

Asset-Based Valuation

Book Value/Share ₹16.8
Liquidation Value/Share ₹-6.12
Fair Value
₹16.8

Discounted Cash Flow (DCF)

Current FCF ₹2.0 Cr
FCF Growth Rate -47.72%
Discount Rate 10.0%
Terminal Growth 3.0%
Enterprise Value ₹2.48 Cr
DCF Fair Value
₹0.42

LASA Fair Value Analysis — Data Sources & Coverage

Lasa Supergenerics financial data sources, valuation methods applied and sector benchmarks used. Analyse Lasa Supergenerics ownership structure to track promoter, FII and institutional holdings.

Methods Used
4
Sector
Healthcare

Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.

LASA vs Healthcare Sector Peers — P/E, P/B & Market Cap

Lasa Supergenerics P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.

Company Symbol P/E Ratio P/B Ratio Market Cap (₹ Cr)
Par Drugs & Chemical PAR - 1.21 ₹132
Sat Kartar Shopping SATKARTAR 29.05 5.53 ₹307
Acutaas Chemicals ACUTAAS 67.94 13.69 ₹19,597
Jeena Sikho Lifecare JSLL 40.04 22.87 ₹8,290
Murae Organisor MURAE 2.86 0.2 ₹41

Important Disclaimer

This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.

This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.

Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.